• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rapid Diagnosis of Influenza: State of the Art

tetano

Editor, Senior Moderator
Clin Lab Med. 2014 Jun;34(2):365-385. doi: 10.1016/j.cll.2014.02.009.
Rapid Diagnosis of Influenza: State of the Art.
Peaper DR1, Landry ML2.
Author information
Abstract

Much effort has been expended developing testing modalities for influenza viruses that are capable of providing rapid results to clinicians. Antigen-detection techniques, historically the only methods able to deliver results quickly, are still widely used despite concerns about sensitivity. Recently, nucleic acid amplification tests (NAATs), which can achieve rapid turnaround times and high sensitivity, have become available. In addition, NAATs can detect other respiratory pathogens. Although there are many theoretical advantages to rapid influenza testing, the clinical impact of testing in various patient populations must be considered against the cost and the analytical performance of the tests.

Copyright ? 2014 Elsevier Inc. All rights reserved.
KEYWORDS:

Antigen, Direct immunofluorescence assays, Influenza, Nucleic acid amplification tests, Polymerase chain reaction, Rapid diagnosis, Respiratory virus

PMID:
24856533
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24856533
 
Back
Top Bottom